| Ms Cafie M Doucette-marks, BACHELOR DEGREE | |
|
8708 Sheldon St, Metairie, LA 70003-6841 | |
| (504) 205-5940 | |
| Not Available |
| Full Name | Ms Cafie M Doucette-marks |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 8708 Sheldon St, Metairie, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952987083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 15453 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Cafie M Doucette-marks, BACHELOR DEGREE 8708 Sheldon St, Metairie, LA 70003-6841 Ph: (504) 205-5940 | Ms Cafie M Doucette-marks, BACHELOR DEGREE 8708 Sheldon St, Metairie, LA 70003-6841 Ph: (504) 205-5940 |
News Archive
Pharmaceutical companies are finding innovative new strategies to retain market share after drug patent expiration. One of the most successful of these new strategies appears to be 'flanking.' Under this strategy, brand-name drug companies sign licensing agreements with their generic competitors to establish manufacturer- distributor relationships.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced it submitted a supplemental New Drug Application with the U.S. Food and Drug Administration (FDA) for a Ready-to-Use formulation of FUSILEV (levoleucovorin) for Injection.
ReWalk Robotics Ltd., the leading global exoskeleton manufacturer, unveiled today the latest edition of its Personal powered exoskeleton system—the ReWalk Personal 6.0—marking the company's sixth generation community use product. The ReWalk Personal 6.0 offers those in the spinal cord injured community the most functional exoskeleton system with the fastest walking speed and the most precise fit, among many other key benefits.
Oncolytics Biotech Inc. announced today the start of enrollment in a randomized Phase II ovarian cancer study. The Gynecologic Oncology Group (GOG) is conducting the randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
A lot of Americans struggle with digestive difficulties with many not knowing how to fit in regular physical activity or make the best dietary choices that can actually promote digestive health.
› Verified 5 days ago
Marion Wikholm, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4322 Loveland St, Metairie, LA 70006 Phone: 504-883-6329 | |
Elsa Rae Pool, PHD LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Codifer Blvd, Ste A, Metairie, LA 70005 Phone: 504-835-6320 Fax: 504-836-6980 | |
Dr. Barry H Pilson, PH.D. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2420 Athania Pkwy, Fl 3, Metairie, LA 70001 Phone: 504-834-2455 Fax: 504-837-3411 | |
Anthony L Digeorge Jr., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 122 Sierra Ct, Metairie, LA 70001 Phone: 504-884-7989 | |
Leslie Kiyanfar, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 701 Papworth Ave, Ste 208, Metairie, LA 70005 Phone: 985-688-5386 | |
Angelika Guidry, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4200 S I 10 Service Rd W Ste 248, Metairie, LA 70001 Phone: 504-810-8096 | |
Hannah Juneau, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1020 Trudeau Dr, Metairie, LA 70003 Phone: 337-962-5102 |